Lynch & Associates Stryker Corp Transaction History

Lynch & Associates

$429 Million
Q1 2024

A detailed history of Lynch & Associates transactions in Stryker Corp stock. As of the latest transaction made, Lynch & Associates holds 17,351 shares of SYK stock, worth $5.85 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

17,351

Previous 18,379 5.59%

Holding current value

$5.85 Million

Previous $5.5 Million 12.83%

% of portfolio

1.45%

Previous 1.35%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	SELL	$293.94 - $358.71 $302,170 - $368,753	-1,028 Reduced 5.59%	17,351 $6.21 Million
Q4 2023 Jan 08, 2024	BUY	$253.85 - $299.46 $28,938 - $34,138	114 Added 0.62%	18,379 $5.5 Million
Q3 2023 Oct 24, 2023	SELL	$266.54 - $302.43 $3,998 - $4,536	-15 Reduced 0.08%	18,265 $4.99 Million
Q2 2023 Oct 24, 2023	SELL	$271.49 - $305.09 $278,277 - $312,717	-1,025 Reduced 5.31%	18,280 $5.58 Million
Q2 2023 Jul 13, 2023	SELL	$271.49 - $305.09 $278,277 - $312,717	-1,025 Reduced 5.31%	18,280 $5.58 Million

Q1 2023 Oct 24, 2023	BUY	$246.13 - $285.47 $252,283 - $292,606	1,025 Added 5.61%	19,305 $5.51 Million
Q1 2023 Apr 04, 2023	SELL	$246.13 - $285.47 $78,515 - $91,064	-319 Reduced 1.63%	19,305 $5.51 Million
Q4 2022 Oct 24, 2023	BUY	$205.51 - $253.93 $279,288 - $345,090	1,359 Added 7.44%	19,624 $4.8 Million
Q4 2022 Jan 05, 2023	SELL	$205.51 - $253.93 $61,447 - $75,925	-299 Reduced 1.5%	19,624 $4.8 Million
Q3 2022 Oct 03, 2022	SELL	$189.27 - $231.83 $18,927 - $23,183	-100 Reduced 0.5%	19,923 $4.04 Million
Q2 2022 Jul 06, 2022	SELL	$194.09 - $276.37 $36,488 - $51,957	-188 Reduced 0.93%	20,023 $3.98 Million
Q1 2022 Apr 08, 2022	SELL	$245.33 - $277.77 $36,308 - $41,109	-148 Reduced 0.73%	20,211 $5.4 Million
Q4 2021 Jan 11, 2022	SELL	$236.63 - $276.44 $3,549 - $4,146	-15 Reduced 0.07%	20,359 $5.44 Million
Q3 2021 Oct 12, 2021	BUY	$248.9 - $280.09 $41,317 - $46,494	166 Added 0.82%	20,374 $5.37 Million
Q2 2021 Jul 21, 2021	SELL	$242.95 - $267.0 $152,329 - $167,409	-627 Reduced 3.01%	20,208 $5.25 Million
Q1 2021 Apr 09, 2021	SELL	$221.01 - $248.82 $88,404 - $99,528	-400 Reduced 1.88%	20,835 $5.08 Million
Q4 2020 Jan 20, 2021	SELL	$202.01 - $245.04 $112,115 - $135,997	-555 Reduced 2.55%	21,235 $5.2 Million
Q3 2020 Oct 21, 2020	SELL	$177.77 - $215.81 $204,435 - $248,181	-1,150 Reduced 5.01%	21,790 $4.54 Million
Q2 2020 Jul 20, 2020	SELL	$144.67 - $207.03 $379,035 - $542,418	-2,620 Reduced 10.25%	22,940 $4.13 Million
Q1 2020 Apr 28, 2020	BUY	$126.5 - $225.1 $11,385 - $20,259	90 Added 0.35%	25,560 $4.26 Million
Q4 2019 Jan 10, 2020	SELL	$197.98 - $220.53 $45,733 - $50,942	-231 Reduced 0.9%	25,470 $5.35 Million
Q3 2019 Oct 03, 2019	SELL	$205.4 - $221.82 $37,793 - $40,814	-184 Reduced 0.71%	25,701 $5.56 Million
Q2 2019 Jul 19, 2019	SELL	$180.24 - $205.58 $54,072 - $61,674	-300 Reduced 1.15%	25,885 $5.32 Million
Q1 2019 Apr 25, 2019	BUY	$152.46 - $198.0 $21,344 - $27,720	140 Added 0.54%	26,185 $5.17 Million
Q4 2018 Jan 10, 2019	SELL	$145.0 - $178.65 $15,225 - $18,758	-105 Reduced 0.4%	26,045 $4.08 Million
Q3 2018 Oct 05, 2018	SELL	$163.25 - $177.68 $57,137 - $62,188	-350 Reduced 1.32%	26,150 $4.65 Million
Q2 2018 Jul 09, 2018	BUY	$155.17 - $179.78 $197,841 - $229,219	1,275 Added 5.05%	26,500 $4.48 Million
Q1 2018 Apr 06, 2018	SELL	$148.01 - $168.91 $307,120 - $350,488	-2,075 Reduced 7.6%	25,225 $4.06 Million
Q4 2017 Jan 04, 2018	SELL	$143.51 - $159.74 $5,309 - $5,910	-37 Reduced 0.14%	27,300 $4.23 Million
Q3 2017 Oct 18, 2017	BUY	$138.36 - $147.87 $3.78 Million - $4.04 Million	27,337	27,337 $3.88 Million

Others Institutions Holding SYK

# of Institutions

2,132

Shares Held

280M

Call Options Held

1.19M

Put Options Held

710K

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $128B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.

Account

Lynch & Associates Stryker Corp Transaction History